title: Endostatin: are the 2 years up yet?
authors.forename: Jan H M
authors.initials: JH
authors.lastname: Schellens
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Ratain
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D003094:Collagen / Q000627:therapeutic use*; D043169:Endostatins; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D043169:Endostatins; D010446:Peptide Fragments; D003094:Collagen